Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Warfarin1件: Warfarin3件: D00564 ,
D01280 ,
D08682 		2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬13件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97
2Warfarin 10 mg1件: Warfarin3件: D00564 ,
D01280 ,
D08682 		2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬2件: 96, 97
3Warfarin Potassium2件: Potassium,
Warfarin		4件: D00564 ,
D01280 ,
D08403 ,
D08682 		2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 88
4Warfarin Sodium1件: Warfarin3件: D00564 ,
D01280 ,
D08682 		2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 49
5Warfarin+ Vitamin K2件: Phylloquinone,
Warfarin		4件: D00148 ,
D00564 ,
D01280 ,
D08682 		2件: NQO1,
VKORC1 💬		7件: Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬1件: 46
6Warm compress prior to injection of glatiramer acetate2件: Acetate,
Glatiramer		1件: D04318 20件: HLA-A,
HLA-B,
HLA-C,
HLA-DMA,
HLA-DMB,
HLA-DOA,
HLA-DOB,
HLA-DPA1,
HLA-DPB1,
HLA-DQA1,
HLA-DQA2,
HLA-DQB1,
HLA-DRA,
HLA-DRB1,
HLA-DRB3,
HLA-DRB4,
HLA-DRB5,
HLA-E,
HLA-F,
HLA-G 💬		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13
7Water1件: Water1件: D00001 --23件: 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299
8Water exercises1件: Water1件: D00001 --1件: 46
9WATER FOR INJECTION1件: Water1件: D00001 --1件: 35
10Water for injections1件: Water1件: D00001 --1件: 299
11WATER FOR INJECTIONS, EP1件: Water1件: D00001 --1件: 299
12WAY-130799----1件: 13
13WAY-177005----1件: 46
14WD-1603----1件: 6
15WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
16WD-1603 Carbidopa-Levodopa Extended-Release Tablets2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
17WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS2件: Carbidopa,
Levodopa		2件: D00059 ,
D00558 		6件: DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬		16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬1件: 6
18Weancare-domus----1件: 6
19Wellbutrin (bupropion)1件: Bupropion3件: D00817 ,
D07591 ,
D07938 		2件: SLC6A2,
SLC6A3 💬		7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬1件: 96
20WFI----1件: 96
21Whale blubber oil----1件: 46
22Wharton Jelly Mesenchymal stem cells----1件: 97
23Wharton's jelly derived mesenchymal stem cell----1件: 90
24WHARTON’S JELLY DERIVED MESENCHYMAL STEM CELLS----1件: 36
25WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS----1件: 2
26Wheat1件: Wheat1件: D06902 --3件: 6, 98, 266
27Wheat bran2件: Wheat,
Wheat bran		1件: D06902 --1件: 6
28Whey protein----2件: 6, 96
29Whey Protein&Prebiotic Supplement----1件: 46
30White chocolate (0% cocoa)1件: Cocoa---1件: 6
31Whole blood sample----1件: 177
32Whole body planar SPECT imaging (15 Minutes post-injection)----1件: 46
33Whole body planar SPECT imaging (18-20 Hours post-injection)----1件: 46
34Whole body planar SPECT imaging (180 Minutes post-injection)----1件: 46
35Whole body planar SPECT imaging (60 Minutes post-injection)----1件: 46
36Whole body Protein turnover----4件: 19, 46, 96, 299
37Whole body Protein Turnover Study----1件: 299
38Whole Lung Lavage(WLL)----1件: 229
39WILATE1件: Von Willebrand factor human---1件: 288
40Wilate 10001件: Von Willebrand factor human---1件: 288
41WILATE 1000 I.U.1件: Von Willebrand factor human---1件: 288
42WILATE 4501件: Von Willebrand factor human---1件: 288
43Wilate 5001件: Von Willebrand factor human---1件: 288
44WILATE 500 I.U.1件: Von Willebrand factor human---1件: 288
45WILATE 9001件: Von Willebrand factor human---1件: 288
46WILATE® 4501件: Von Willebrand factor human---1件: 288
47WILFACTIN----1件: 288
48Willfact----1件: 288
49Wiloctin----1件: 288
50Wilzin1件: Zinc---1件: 171
51WIN-1001X----1件: 6
52With U-VANCO (vancomycin hydrochloride)1件: Vancomycin2件: D00212 ,
D00926 		--1件: 70
53Withania somnifera----1件: 2
54Without U-VANCO (vancomycin hydrochloride)1件: Vancomycin2件: D00212 ,
D00926 		--1件: 70
55WJ-MSCs1件: Human Umbilical Cord Mesenchymal Stem Cells---1件: 36
56WLL----1件: 229
57WM (Shentong Granules)----1件: 66
58WMT----1件: 96
59Wound topically irrigated with 500mg TXA----1件: 70
60Wristband physical activity monitor1件: Methamidophos---1件: 13
61WTX101----1件: 171
62Wuling Powder----1件: 6
63WVE-003----1件: 8
64WVE-004----2件: 2, 127
65WVE-120101----1件: 8
66WVE-120102----1件: 8
67WVE-210201----1件: 113
68WVE-210201 (suvodirsen)----1件: 113
69WVE-N531----1件: 113